Clinical Trial

A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers

Name: A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers — clinical trial record (NCT07586514)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This study will dose healthy human volunteers with either active drug (4ET1103) or placebo. Each study subject will receive a single dose of either active drug or placebo, and will then be monitored for safety, tolerability and exposure of active drug.

Trial Details

NCT Number	NCT07586514
Lead Sponsor	4E Therapeutics Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions	Neuropathic Pain
Enrollment	40 participants
Start Date	2025-04-18
Primary Completion	2025-08-18 (estimated)
Study Completion	2025-08-18 (estimated)
Updated on ClinicalTrials.gov	2026-05-14